Astrea Acquisition Corp. (NASDAQ:ASAX – Get Rating) saw a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 12,200 shares, a decline of 88.7% from the October 31st total of 108,000 shares. Based on an average trading volume of 32,800 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.1% of the company's shares are sold short.
Hedge Funds Weigh In On Astrea Acquisition
Large investors have recently bought and sold shares of the business. Elequin Capital LP purchased a new position in Astrea Acquisition during the 3rd quarter valued at $25,000. Dark Forest Capital Management LP purchased a new stake in shares of Astrea Acquisition in the 2nd quarter worth $94,000. Centiva Capital LP purchased a new stake in shares of Astrea Acquisition in the 2nd quarter worth $160,000. Glazer Capital LLC purchased a new stake in shares of Astrea Acquisition in the 3rd quarter worth $199,000. Finally, Exos TFP Holdings LLC purchased a new stake in shares of Astrea Acquisition in the 3rd quarter worth $211,000. Hedge funds and other institutional investors own 76.06% of the company's stock.
Get Astrea Acquisition alerts:Astrea Acquisition Stock Performance
ASAX opened at $10.03 on Wednesday. The business has a fifty day moving average of $9.91 and a 200 day moving average of $9.85. Astrea Acquisition has a 52-week low of $8.17 and a 52-week high of $10.04.
About Astrea Acquisition
(Get Rating)Astrea Acquisition Corp. does not have significant operations. It intends to enter a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company focuses on the businesses in the food and beverage/hospitality, financial services, technology, consumer, real estate and transportation, telecom and media, and industrial sectors.
Further Reading
- Get a free copy of the StockNews.com research report on Astrea Acquisition (ASAX)
- Struggling Axsome Stock Could Bounce Back on Drug Trial Success
- Which Stocks Are Black Friday, Cyber Monday Winners & Losers?
- Three Reasons It's Time To Get Bullish On Organigram
- Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
- Why Investors Are Eating Up Restaurant Brands International
Receive News & Ratings for Astrea Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrea Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.